
Leap Therapeutics Reports Third Quarter 2024 Financial Results
Published on January 2, 2025
FL-501 into development. With a strong cash position that is expected to fund operations into Q2 2026, Leap is well positioned for continued

FL-501 into development. With a strong cash position that is expected to fund operations into Q2 2026, Leap is well positioned for continued